The Trump administration has initiated significant changes affecting federally funded research, particularly targeting Diversity, Equity, and Inclusion (DEI) initiatives. At NYU Langone Health, employees have been directed to avoid DEI-related terms in communications to align with new federal guidelines scrutinizing such language in funded programs, including in National Institutes of Health (NIH) research grants. This reflects a broader national debate on the role of DEI in public institutions.
Concurrently, the NIH has experienced unprecedented grant terminations. Historically, the NIH cancels approximately 20 out of 60,000 grants annually, typically due to severe issues like fraud. However, under the current administration, over 100 grants have been terminated, with expectations of more to follow. These cancellations predominantly affect projects related to DEI, transgender issues, and vaccine hesitancy, causing confusion and instability within the biomedical research community.
Additionally, the administration’s decision to cap indirect cost reimbursements for grants at 15% has strained research institutions. Indirect costs, covering essential infrastructure and administrative support, typically range from 30% to 70%. The abrupt reduction has led to financial deficits, job losses, and the scaling back of research programs. For instance, Johns Hopkins University eliminated nearly 2,000 jobs following an $800 million grant cut.
Key Implications for Health Systems:
To navigate these challenges and protect research funding, hospital leaders should clearly communicate how to:
- Highlight Research Excellence: Focus on the institution’s commitment to high-quality, innovative research that addresses our nation’s critical health issues, demonstrating the value and impact of funded projects – including high-paying jobs for those supporting the research – from scientists to janitors.
- Emphasize Compliance: Ensure all communications and grant applications align with current federal guidelines, avoiding language or initiatives that could jeopardize funding. Further, highlight any grants that meet the new 15% cap on indirect costs and continue to deliver on results.
- Engage in Advocacy: Collaborate with peer institutions and professional organizations to advocate for policies that support sustainable research funding and infrastructure.
- Diversify Funding Sources: Explore alternative funding avenues, such as private foundations, industry partnerships, and philanthropic contributions, to mitigate reliance on federal funds.
Maintain Transparency: Communicate openly with stakeholders, including staff, patients, and the public, about the institution’s strategies to uphold research integrity and financial stability amid funding challenges.